Search for clinical trials.
A Focus On Science
NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.
Our Mission
Improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research
Dr. Robert S. Mannel
Our exceptional network brings individuals together who are passionate about changing the future of cancer care through impactful clinical trials.
Membership Resources
NRG Oncology’s membership roster is comprised of over 1,000 member sites including institutions on five continents. Our investigators represent all of the oncologic medical specialties and disciplines.
Learn MoreLatest News
NRG Oncology Trial Results Show Favorable Bowel Health Related Quality of Life Outcomes for Localized Immediate Risk Prostate Cancer Treated with Stereotactic Body Radiation Therapy – Results Published
Patient-Reported Outcome Analysis of NRG Oncology Trial in Limited-Stage Small Cell Lung Cancer Suggests More Favorable Quality-of-Life Trajectory with Twice-Daily versus Once-Daily Radiation – Results Published
NRG Oncology Received a Perfect Grant Score and Increased Funding from the National Cancer Institute
Stay current with science. Sign up for our newsletter.
Support NRG Oncology.
Help Our Cause.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More